Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Comparison of QoL Between Trabectedin/PLD and Standard Platinum-based Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer (COMPASS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03164980
Recruitment Status : Recruiting
First Posted : May 24, 2017
Last Update Posted : April 6, 2022
Institute of Clinical Cancer Research (IKF)
Information provided by (Responsible Party):
North Eastern German Society of Gynaecological Oncology

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2024
Estimated Study Completion Date : March 2024